Skip to content

Evaluation of Pharmacist Intervention for improving Adherence of Immunosuppressive Regimen in Kidney Transplant Recipients

Evaluation of Pharmacist Intervention for Improving Adherence of Immunosuppressive Regimen includes Calcineurin Inhibitors and Measuring Blood Levels of the Immunosuppressive Agents in Kidney Transplant Recipients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150706023084N9
Enrollment
50
Registered
2021-07-21
Start date
2021-07-01
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplant. Kidney transplant status

Interventions

Intervention 1: Intervention group:It consists of 25 people, each of whom, in addition to receiving a guidebook, includes all educational, behavioral and reinforcement actions and routine clinical app

Sponsors

Islamic Azad University, Pharmaceutical Sciences Branch
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Conscious satisfaction of the patient to participate in the study Age between 18 to 60 years Patients with kidney disease confirmed by doctors, kidney transplant have been done and at least 3 years have passed since their transplant Consumption of Immunosuppressive drug

Exclusion criteria

Exclusion criteria: Reluctance to continue participating in the study Drug abuse Drug allergy Infection

Design outcomes

Primary

MeasureTime frame
Adherence score in the Morisky Questionnaire. Timepoint: Measurement of adherence scores in the Morisky Questionnaire before the intervention and then in meetings at intervals of 2 months. Method of measurement: The 8-item Morisky Medication Adherence Scale (MMAS-8).;Blood levels of Immunosuppressive drugs. Timepoint: Measurement of blood levels of Immunosuppressive drugs before the intervention and then at appointments at intervals of 2 months. Method of measurement: Blood test.;Intra-Patient Variability (IPV) of Immunosuppressive drugs. Timepoint: Measurement of Intra-Patient Variability (IPV) of Immunosuppressive drugs before the intervention and then at appointments at intervals of 2 months. Method of measurement: Percent of Mean Absolute Deviation (MAD) formula.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRokhshad Gharehcheloo

Islamic Azad University

Rokhshad_gh@yahoo.com+98 26 3274 4461

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026